Estrella Immunopharma Inc... (ESLA)
NASDAQ: ESLA
· Real-Time Price · USD
1.02
0.01 (1.03%)
At close: Jun 02, 2025, 3:51 PM
1.02
0.00%
After-hours: Jun 02, 2025, 07:07 PM EDT
1.03% (1D)
| Bid | 1.01 |
| Market Cap | 36.89M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.82M |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -4.25 |
| Forward PE | -2.17 |
| Analyst | Buy |
| Ask | 1.04 |
| Volume | 4,024 |
| Avg. Volume (20D) | 53,076 |
| Open | 0.98 |
| Previous Close | 1.01 |
| Day's Range | 0.96 - 1.02 |
| 52-Week Range | 0.63 - 3.23 |
| Beta | 0.41 |
About ESLA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ESLA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ESLA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+16.13%
Estrella Immunopharma shares are trading higher af...
Unlock content with
Pro Subscription
8 months ago
+22.69%
Estrella Immunopharma shares are trading higher after the company announced rhat the first patient enrolled in its STARLIGHT-1 Phase I/II clinical trial has achieved a complete response one month after receiving an infusion of EB103 CD19- Redirected ARTEMIS T Cells.
